Efavirenz, Lamivudine and Tenofovir Disoproxil (SYMFI)
Questions a plan sponsor actually asks.
What is Efavirenz, Lamivudine and Tenofovir Disoproxil used for?
Efavirenz, Lamivudine and Tenofovir Disoproxil is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Efavirenz, Lamivudine and Tenofovir Disoproxil?
Yes. 2 ANDAs filed at FDA, 1 generic manufacturers currently shipping.
How much does my plan pay for Efavirenz, Lamivudine and Tenofovir Disoproxil?
NADAC pricing data not currently available for this drug.
Is Efavirenz, Lamivudine and Tenofovir Disoproxil on the FDA shortage list?
No. Efavirenz, Lamivudine and Tenofovir Disoproxil is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.